Todd Bazemore - 29 Aug 2025 Form 4 Insider Report for KALA BIO, Inc. (KALA)

Reporting relationship: President and Chief Executive Officer, Director
Issuer ticker: KALA
Reported as of: 29 Aug 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Sep 2025, 16:08:52 UTC
Prior SEC filing: 26 Jun 2025
Next SEC filing: 24 Oct 2025
Source filing: View source filing
Reporting owner signature: /s/ Mary Reumuth, Attorney-in-Fact

Key filing fact

Todd Bazemore filed Form 4 for KALA BIO, Inc. (KALA) on 02 Sep 2025.

Key facts

This page summarizes Todd Bazemore's Form 4 filing for KALA BIO, Inc. (KALA).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 02 Sep 2025, 16:08.

Change

Previous filing in this sequence was filed on 26 Jun 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001605767 Primary reporting owner

Bazemore Todd

Relationship: President and Chief Executive Officer, Director
Address: C/O KALA BIO, INC., 1167 MASSACHUSETTS AVENUE, ARLINGTON
Signature: /s/ Mary Reumuth, Attorney-in-Fact
Signature date: 02 Sep 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KALA transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +180,000
Change %
Price: $0.000000
Shares after: 180,000
Date: 29 Aug 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 180,000
Exercise price: $11.22
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This option was granted on August 29, 2025 and vests over four years beginning on the vesting commencement date of August 29, 2025, with 1/48th of the shares underlying the option vesting at the end of each successive one-month period thereafter until August 29, 2029, subject to the Reporting Person's continued service.

SEC remarks

President and Chief Executive Officer